US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 3.3100
  • 0.00000.00%
Trading Jul 19 15:58 ET
8.97MMarket Cap10.03P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
-91.05%297K
0
0
-97.60%72K
Operating revenue
--0
--0
--0
--0
--0
--0
-91.05%297K
--0
--0
-97.60%72K
Cost of revenue
Gross profit
Operating expense
-50.60%1.62M
-48.79%9.65M
-59.71%1.8M
-40.00%2.71M
-68.58%4.24M
-75.21%3.28M
-67.32%18.84M
-69.32%4.46M
-60.24%4.52M
-26.18%13.51M
Selling and administrative expenses
-41.77%1.57M
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-4.66%3.36M
-31.60%2.7M
-37.64%12.86M
-25.70%3.28M
-32.54%3.1M
-43.58%3.52M
-General and administrative expense
-41.77%1.57M
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-4.66%3.36M
-31.60%2.7M
-37.64%12.86M
-25.70%3.28M
-32.54%3.1M
-43.58%3.52M
Research and development costs
-92.31%44K
-74.66%1.52M
-97.96%24K
-58.98%580K
-91.33%886K
-94.13%572K
-84.11%5.98M
-88.76%1.18M
-79.89%1.41M
-15.23%10.22M
Other operating expenses
----
----
----
----
----
----
----
----
----
---234K
Operating profit
50.60%-1.62M
47.97%-9.65M
59.71%-1.8M
40.00%-2.71M
68.41%-4.24M
74.78%-3.28M
65.87%-18.54M
68.93%-4.46M
59.96%-4.52M
12.17%-13.43M
Net non-operating interest income expense
-13.64%76K
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
1,366.67%88K
1,937.50%294K
13,300.00%132K
2,320.00%111K
850.00%45K
Non-operating interest income
-13.64%76K
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
--88K
--294K
--132K
--111K
--45K
Other net income (expense)
-3.3M
0
-3.3M
Special income (charges)
----
---3.3M
--0
---3.3M
----
----
--0
--0
--0
----
-Less:Impairment of capital assets
----
--3.3M
--0
--3.3M
----
----
--0
--0
--0
----
Income before tax
51.62%-1.54M
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
68.77%-4.18M
75.44%-3.19M
64.67%-18.25M
59.88%-4.32M
60.97%-4.41M
17.27%-13.39M
Income tax
Net income
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
17.27%-13.39M
Net income continuous Operations
51.62%-1.54M
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
68.77%-4.18M
75.44%-3.19M
64.67%-18.25M
59.88%-4.32M
60.97%-4.41M
17.27%-13.39M
Net income discontinuous operations
--0
128.38%7.33M
--0
321.28%13.47M
----
---3.77M
---25.83M
---2.89M
---6.09M
----
Minority interest income
Net income attributable to the parent company
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
17.27%-13.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
17.27%-13.39M
Basic earnings per share
80.63%-0.62
88.91%-2.25
78.92%-0.7
164.39%3.11
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
7.12%-4.83
31.56%-6.16
Diluted earnings per share
80.63%-0.62
88.91%-2.25
78.92%-0.7
156.31%2.72
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
7.12%-4.83
31.56%-6.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 000000-91.05%297K00-97.60%72K
Operating revenue --0--0--0--0--0--0-91.05%297K--0--0-97.60%72K
Cost of revenue
Gross profit
Operating expense -50.60%1.62M-48.79%9.65M-59.71%1.8M-40.00%2.71M-68.58%4.24M-75.21%3.28M-67.32%18.84M-69.32%4.46M-60.24%4.52M-26.18%13.51M
Selling and administrative expenses -41.77%1.57M-36.76%8.13M-45.99%1.77M-31.35%2.13M-4.66%3.36M-31.60%2.7M-37.64%12.86M-25.70%3.28M-32.54%3.1M-43.58%3.52M
-General and administrative expense -41.77%1.57M-36.76%8.13M-45.99%1.77M-31.35%2.13M-4.66%3.36M-31.60%2.7M-37.64%12.86M-25.70%3.28M-32.54%3.1M-43.58%3.52M
Research and development costs -92.31%44K-74.66%1.52M-97.96%24K-58.98%580K-91.33%886K-94.13%572K-84.11%5.98M-88.76%1.18M-79.89%1.41M-15.23%10.22M
Other operating expenses ---------------------------------------234K
Operating profit 50.60%-1.62M47.97%-9.65M59.71%-1.8M40.00%-2.71M68.41%-4.24M74.78%-3.28M65.87%-18.54M68.93%-4.46M59.96%-4.52M12.17%-13.43M
Net non-operating interest income expense -13.64%76K21.77%358K-23.48%101K-3.60%107K37.78%62K1,366.67%88K1,937.50%294K13,300.00%132K2,320.00%111K850.00%45K
Non-operating interest income -13.64%76K21.77%358K-23.48%101K-3.60%107K37.78%62K--88K--294K--132K--111K--45K
Other net income (expense) -3.3M0-3.3M
Special income (charges) -------3.3M--0---3.3M----------0--0--0----
-Less:Impairment of capital assets ------3.3M--0--3.3M----------0--0--0----
Income before tax 51.62%-1.54M30.98%-12.59M60.81%-1.69M-34.06%-5.91M68.77%-4.18M75.44%-3.19M64.67%-18.25M59.88%-4.32M60.97%-4.41M17.27%-13.39M
Income tax
Net income 77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M17.27%-13.39M
Net income continuous Operations 51.62%-1.54M30.98%-12.59M60.81%-1.69M-34.06%-5.91M68.77%-4.18M75.44%-3.19M64.67%-18.25M59.88%-4.32M60.97%-4.41M17.27%-13.39M
Net income discontinuous operations --0128.38%7.33M--0321.28%13.47M-------3.77M---25.83M---2.89M---6.09M----
Minority interest income
Net income attributable to the parent company 77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M17.27%-13.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M17.27%-13.39M
Basic earnings per share 80.63%-0.6288.91%-2.2578.92%-0.7164.39%3.1170.29%-1.8346.67%-3.223.18%-20.2830.83%-3.327.12%-4.8331.56%-6.16
Diluted earnings per share 80.63%-0.6288.91%-2.2578.92%-0.7156.31%2.7270.29%-1.8346.67%-3.223.18%-20.2830.83%-3.327.12%-4.8331.56%-6.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.42%